• Biology
  • Published 2006

Compositions and methods for treating tumours presenting survivin antigens

@inproceedings{2006CompositionsAM,
  title={Compositions and methods for treating tumours presenting survivin antigens},
  author={Стефен Д. Джиллиз and Тор А.О. Хеттманн and Паскаль Андре Стейн and Стефан Джи Клайнц},
  year={2006}
}
FIELD: medicine, pharmaceutics. SUBSTANCE: invention refers to biotechnology. Described is a vaccine eliciting a survivin immune response in an individual, containing peptide or nucleic acid coding peptide originated from mutant hen's survivin containing BIR-domain having 50%-90% amino acid identity to BIR-domain found Asp 16 to Leu87 in human survivin, and containing N97E, T99M, V100L and Q101G mutations which promote the T-cell presentation of an antigen by fixation to MHC molecules, and said… CONTINUE READING

Figures and Tables from this paper.

References

Publications referenced by this paper.
SHOWING 1-3 OF 3 REFERENCES

Other attenuated Salmonella strains also may be used. Such as RE88, with the genotype aroA, dam VNP20009, with the genotype

  • SL strain
  • 2000
VIEW 2 EXCERPTS

3:917-921). BaF3 cells are transfected with plasmids encoding a Survivin construct of the inven

  • Nat. Med
  • 1997

125:191), antibody heavy chain signal sequences

  • Gillies
  • 1989
VIEW 1 EXCERPT